title: C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome.
abstract: Acute respiratory distress syndrome (ARDS) is characterized by the presence of fibrin-rich inflammatory exudates in the intra-alveolar spaces and the extensive migration of neutrophils into alveoli of the lungs. Tissue factor (TF)-dependent procoagulant properties of bronchoalveaolar lavage fluid (BALF) obtained from ARDS patients favor fibrin deposition, and are likely the result of cross-talk between inflammatory mediators and hemostatic mechanisms. However, the regulation of these interactions remains elusive. Prompted by previous findings suggesting that neutrophils, under certain inflammatory conditions, can express functional TF, we investigated the contribution of intra-alveolar neutrophils to the procoagulant properties of BALF from patients with ARDS. Our results confirm that the procoagulant properties of BALF from ARDS patients are the result of TF induction, and further indicate that BALF neutrophils are a main source of TF in intra-alveolar fluid. We also found that BALF neutrophils in these patients express significantly higher levels of TF than peripheral blood neutrophils. These results suggest that the alveolar microenvironment contributes to TF induction in ARDS. Additional experiments indicated that the ability of BALF to induce TF expression in neutrophils from healthy donors can be abolished by inhibiting C5a or TNF-alpha signaling, suggesting a primary role for these inflammatory mediators in the up-regulation of TF in alveolar neutrophils in ARDS. This cross-talk between inflammatory mediators and the induction of TF expression in intra-alveolar neutrophils may be a potential target for novel therapeutic strategies to limit ARDS-associated disturbances of coagulation.
authors.affiliation: First Division of Internal Medicine, Democritus uNiversity of Thrace, Alexandoupolis, Greece.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Kambas
authors.forename: Maciej M
authors.initials: MM
authors.lastname: Markiewski
authors.forename: Ioannis A
authors.initials: IA
authors.lastname: Pneumatikos
authors.forename: Stavros S
authors.initials: SS
authors.lastname: Rafail
authors.forename: Vassiliki
authors.initials: V
authors.lastname: Theodorou
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Konstantonis
authors.forename: Ioannis
authors.initials: I
authors.lastname: Kourtzelis
authors.forename: Michael N
authors.initials: MN
authors.lastname: Doumas
authors.forename: Paola
authors.initials: P
authors.lastname: Magotti
authors.forename: Robert A
authors.initials: RA
authors.lastname: Deangelis
authors.forename: John D
authors.initials: JD
authors.lastname: Lambris
authors.forename: Konstantinos D
authors.initials: KD
authors.lastname: Ritis
mesh_terms: D000328:Adult; D000368:Aged; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology / Q000276:immunology; D015936:Complement C5a / Q000276:immunology / Q000378:metabolism*; D016207:Cytokines / Q000276:immunology / Q000378:metabolism*; D005337:Fibrin / Q000276:immunology / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D009504:Neutrophils / Q000276:immunology / Q000378:metabolism*; D012128:Respiratory Distress Syndrome / Q000276:immunology / Q000378:metabolism*; D013925:Thromboplastin / Q000276:immunology / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000378:metabolism*
chemical_list: D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha; D015936:Complement C5a; D005337:Fibrin; D013925:Thromboplastin